Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Everforth Inc. (EFOR)
NYSEInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
$36.98+7.97%
Close 2026-11-04 · 1-day change
NYSEInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.28 → 4.24 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for EFOR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS near $0.26 next quarter | Everforth makes rapid diagnostic tests with steady sales near $1B next quarter. | Intact | EPS falls below $0.19 next quarter | Diluted EPS: $0.56 per share FY2026-Q3; GAAP. Published target: >= $0.19. Target period ends 2026-06-30; this observation covers 2026-Q3. Oct 30, 20260.56 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
EFOR is a higher-risk growth and execution story, with management focused on AI and data services. The long-term thesis is intact, though the latest signal has shifted from mildly favorable to mixed as company momentum weakened.
The valuation evidence describes EFOR as cheap versus peers, while the expectations gap is negative, suggesting expectations are subdued. The priced-in assessment is tagged justified, with low fragility, but that does not remove the risk that weaker results or guidance could pressure the business outlook.
Near term, recent earnings beats and revenue growth are constructive, but momentum has fallen and profitability has weakened: operating income and gross margin were lower year over year in 2026-Q3. Management has made progress on debt reduction and revenue growth, while quantified evidence of AI-services adoption remains limited; a guidance cut is a stated risk.
Over the next few quarters, the thesis depends on revenue growth translating into stronger profitability and on management delivering measurable growth in AI and data services. A guidance cut would be a meaningful negative, while lower interest rates or stabilization among large technology peers could support the sector backdrop.
Over a 1-3 year view, EFOR offers a cheap-versus-peers valuation and an intact growth thesis, but high risk and weaker momentum make execution and margin improvement central. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Everforth Inc.'s published investment case. The stated target is >= 28.3%. |
| Broken |
| Gross margin falls below 28.3% next quarter |
Gross margin: 28.27% FY2026-Q3; GAAP. Published target: >= 28.3%. Target period ends 2026-06-30; this observation covers 2026-Q3. Oct 30, 202628.272251 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue near $985M next quarter | Everforth makes rapid diagnostic tests with steady sales near $1B next quarter. | Intact | Revenue falls below $970M next quarter | Revenue: $1.031B FY2026-Q3; GAAP. Published target: >= $970M. Target period ends 2026-06-30; this observation covers 2026-Q3. Oct 30, 20261,031,400,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain valuation discount with PE near 4.25 | A supporting condition in Everforth Inc.'s published investment case. The stated target is PE <= 5. | Broken | PE rises above 7 without earnings growth | P/E (TTM): 9.58x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 20269.5803 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.36 → $4.24 · observed estimates
$4.04B → $4.09B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.36 | $4,042,487,246 | 4 / 5 |
| 2026-07-25 | $4.36 | $4,042,511,370 | 7 / 7 |
| 2026-07-26 | $4.36 | $4,042,487,246 | 4 / 5 |
| 2026-07-27 | $4.36 | $4,042,511,370 | 7 / 7 |
| 2026-07-28 | $4.36 | $4,042,487,246 | 4 / 5 |
| 2026-07-29 | $4.36 | $4,042,511,370 | 7 / 7 |
| 2026-07-30 | $4.36 | $4,042,511,370 | 7 / 7 |
| 2026-07-31 | $4.30 | $4,068,084,343 | 4 / 5 |
| 2026-08-01 | $4.30 | $4,068,084,343 | 4 / 5 |
| 2026-08-02 | $4.30 | $4,066,927,290 | 7 / 7 |
| 2026-08-03 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-04 | $4.30 | $4,066,927,290 | 7 / 7 |
| 2026-08-05 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-06 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-07 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-08 | $4.30 | $4,066,927,290 | 7 / 7 |
| 2026-08-09 | $4.30 | $4,066,927,290 | 7 / 7 |
| 2026-08-10 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-11 | $4.30 | $4,066,927,290 | 7 / 7 |
| 2026-08-12 | $4.30 | $4,066,927,290 | 7 / 7 |
| 2026-08-13 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-14 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-15 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-16 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-17 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-18 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-19 | $4.30 | $4,066,984,343 | 5 / 5 |
| 2026-08-20 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-21 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-22 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-23 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-24 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-25 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-26 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-27 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-28 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-29 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-30 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-08-31 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-09-01 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-09-02 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-09-03 | $4.28 | $4,064,741,486 | 5 / 5 |
| 2026-09-04 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-05 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-06 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-07 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-08 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-09 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-10 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-11 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-12 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-13 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-14 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-15 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-16 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-17 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-18 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-19 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-20 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-21 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-22 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-23 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-24 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-25 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-26 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-27 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-28 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-29 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-09-30 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-01 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-02 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-03 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-04 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-05 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-06 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-07 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-08 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-09 | $4.28 | $4,064,770,143 | 5 / 5 |
| 2026-10-10 | $4.29 | $4,066,386,200 | 5 / 5 |
| 2026-10-11 | $4.29 | $4,066,386,200 | 5 / 5 |
| 2026-10-12 | $4.29 | $4,066,386,200 | 5 / 5 |
| 2026-10-13 | $4.29 | $4,066,386,200 | 5 / 5 |
| 2026-10-14 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-15 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-16 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-17 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-18 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-19 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-20 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-21 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-22 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-23 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-24 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-25 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-26 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-27 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-28 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-29 | $4.34 | $4,066,386,200 | 5 / 5 |
| 2026-10-30 | $4.27 | $4,083,625,674 | 5 / 5 |
| 2026-10-31 | $4.24 | $4,086,316,531 | 5 / 5 |
| 2026-11-01 | $4.24 | $4,086,316,531 | 5 / 5 |
| 2026-11-02 | $4.24 | $4,086,316,531 | 5 / 5 |
| 2026-11-03 | $4.24 | $4,086,279,959 | 5 / 5 |
| 2026-11-04 | $4.24 | $4,086,279,959 | 4 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 4 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 4 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.